| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Unité Propre de Recherche de l’ Enseignement Supérieur-Jeune Equipe 1992 "Interactions Hôte-Greffon", Laboratoire d’Immunologie, Faculté de Médecine, Tours cedex, France
To investigate the mechanisms of cellular rejection in pig-to-human xenotransplantation, the proliferation of different human purified lymphocyte subpopulations in response to swine leukocyte Ag class II-negative porcine aortic endothelial cells (PAEC) was measured in the presence or absence of human autologous adherent cells (huAPC). CD8+ lymphocytes proliferated moderately in the absence of huAPC, and the immune response was slightly increased when huAPC were added. CD56+ lymphocytes failed to proliferate in response to PAEC whether huAPC were present or not. CD4+ lymphocytes alone did not proliferate in response to PAEC, but a strong proliferative response was observed in the presence of metabolically active huAPC. This response was totally abolished by mAbs directed against HLA class II molecules or by pretreatment of huAPC by human IL-10. Even in the presence of huAPC, CD4+ lymphocytes failed to respond to fixed PAEC or to PAEC-lysates, suggesting that PAEC must be viable to support lymphocyte proliferation. Finally, none of the nonendothelial porcine adherent cells tested was able to induce human lymphocyte proliferation, despite the fact that they also provided a large set of xenogeneic peptides. Our results show that the indirect presentation pathway of xenoantigens by huAPC to CD4+ lymphocytes is crucial in the response to porcine endothelial cells, and that IL-10 could be of therapeutic interest to prevent human lymphocyte activation by this pathway. Furthermore, we demonstrated that stimulatory signals specifically provided by endothelial cells are also necessary for this huAPC-restricted proliferative response.
This article has been cited by other articles:
|
|
 |
|
  A. S. Narang and R. I. Mahato Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Methe, H. M. Nugent, A. Groothuis, P. Seifert, M. H. Sayegh, and E. R. Edelman Matrix Embedding Alters the Immune Response Against Endothelial Cells In Vitro and In Vivo Circulation, August 30, 2005; 112(9_suppl): I-89 - I-95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sharland, A. Patel, J. H. Lee, A. E. Cestra, S. Saidman, and G. L. Waneck Genetically Modified HLA Class I Molecules Able to Inhibit Human NK Cells Without Provoking Alloreactive CD8+ CTLs J. Immunol., April 1, 2002; 168(7): 3266 - 3274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhan, J. L. Brady, R. M. Sutherland, and A. M. Lew Without CD4 Help, CD8 Rejection of Pig Xenografts Requires CD28 Costimulation But Not Perforin Killing J. Immunol., December 1, 2001; 167(11): 6279 - 6285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Denton, C. S. Geehan, S. I. Alexander, M. H. Sayegh, and D. M. Briscoe Endothelial Cells Modify the Costimulatory Capacity of Transmigrating Leukocytes and Promote Cd28-Mediated Cd4+ T Cell Alloactivation J. Exp. Med., August 16, 1999; 190(4): 555 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. DerSimonian, L. Pan, C. Yatko, A. Rodrigue-Way, E. Johnson, and A. S. B. Edge Human Anti-Porcine T Cell Response: Blocking with Anti-Class I Antibody Leads to Hyporesponsiveness and a Switch in Cytokine Production J. Immunol., June 15, 1999; 162(12): 6993 - 7001. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
